These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2329921)

  • 21. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Full and partial 5-HT1A receptor agonists disrupt learning and performance in rats.
    Winsauer PJ; Rodriguez FH; Cha AE; Moerschbaecher JM
    J Pharmacol Exp Ther; 1999 Jan; 288(1):335-47. PubMed ID: 9862788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
    Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
    Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties.
    Assié MB; Koek W
    Eur J Pharmacol; 1996 May; 304(1-3):15-21. PubMed ID: 8813579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission.
    Costa L; Trovato C; Musumeci SA; Catania MV; Ciranna L
    Hippocampus; 2012 Apr; 22(4):790-801. PubMed ID: 21538661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis.
    Fujii T; Yoshizawa M; Nakai K; Fujimoto K; Suzuki T; Kawashima K
    Brain Res; 1997 Jul; 761(2):244-9. PubMed ID: 9252022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is NAN-190 an effective antagonist of the hypothermia and hyperglycemia induced by the 5-HT1A receptor agonist, 8-OH-DPAT?
    Wozniak KM; Durcan MJ; Linnoila M
    Eur J Pharmacol; 1991 Feb; 193(2):253-6. PubMed ID: 1828770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.
    Done CJ; Sharp T
    Neuropharmacology; 1994; 33(3-4):411-21. PubMed ID: 7984279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo.
    Gartside SE; Cowen PJ; Hjorth S
    Eur J Pharmacol; 1990 Dec; 191(3):391-400. PubMed ID: 1964908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo interactions of NAN-190, a putative selective 5-HT1A antagonist, with ipsapirone.
    Deans C; Leathley M; Goudie A
    Pharmacol Biochem Behav; 1989 Dec; 34(4):927-9. PubMed ID: 2623048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.
    Sharp T; McQuade R; Fozard JR; Hoyer D
    Br J Pharmacol; 1993 Jul; 109(3):699-702. PubMed ID: 8102935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivo.
    Millan MJ; Rivet JM; Audinot V; Gobert A; Lejeune F; Brocco M; Newman-Tancredi A; Maurel-Remy S; Bervoets K
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1418-27. PubMed ID: 7791116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release--II NAN-190 and SDZ 216-525.
    Sharp T; Umbers V; Hjorth S
    Neuropharmacology; 1996 Jun; 35(6):735-41. PubMed ID: 8887982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.